Clinical investigators provide concise comments on the course of therapy for patients with metastatic adenocarcinoma or squamous cell non-small cell lung cancer in the first-line and maintenance treatment settings. Featuring perspectives from Drs Nasser H Hanna, John Heymach, Mark G Kris, Primo N Lara Jr, Rogerio C Lilenbaum, Thomas J Lynch Jr, Alan B Sandler, Lecia V Sequist, Mark A Socinski and Heather Wakelee. (Text Content)